Dear Editor,

We read the article by Singh et al. with great interest and appreciate the description of various radiological findings on computed tomography in COVID-19 patients. However, these findings are not specific for COVID-19 and have been described in other pulmonary conditions which can be both infective like other viral, bacterial pneumonias and non-infective inflammatory conditions like hypersensitivity pneumonitis and ANCA associated vasculitis \[[@bib1]\]. In geographical areas with endemic influenza and other respiratory viral infections during flu seasons, there may be overlap in the findings on radiological as well as clinical features \[[@bib1],[@bib2]\]. Here we would like to highlight more points about CT imaging features in COVID-19 patients.1.In early stages of illness (0--4 days) around 21% cases have normal CT scans \[[@bib3]\].2.Abnormalities on CT evolve with progression of the disease starting from ground glass opacities and leading on to crazy paving pattern, linear opacities, consolidation, bilateral and peripheral involvement. In staging based on duration of symptoms in days from stage-1 (0--4), stage-2 (5--9), stage-3 (10--14), stage-4 (15--21), stage-5(22--28), stage-6 (\>28); there were different peak of radiological findings in various stages; like crazy paving pattern at stage 3, consolidation at stage 4 and linear opacity at stage 5 \[[@bib3]\]. Older patients have more extensive lesions and worse prognosis than younger patients \[[@bib2]\].3.There have been reports of patients with negative RT-PCR having typical radiological features on CT imaging and turning positive at later stage. Sensitivity of CT findings have been found to be higher than RT-PCR in early stages (98% vs 71% respectively). Various causes of negative RT-PCR are incorrect sampling technique, inadequate viral material in the sample, improper processing of nucleic acid from sample, reagent issues and technical problems \[[@bib2]\].4.Pleural effusion has been documented to varying extent in various studies and is usually present in later stages \[[@bib3], [@bib4], [@bib5]\].

In the presence of considerable overlapping of clinical and radiological features among the different infective or non-infective pneumonias molecular testing and bacterial or viral cultures for isolation and identification of the pathogens are the best method for definitive diagnosis. In areas with endemic H1N1 infections or concomitant seasonal viral influenza, suspicion of co-infection and secondary bacterial infection also has to be kept. In these areas RT-PCR of throat/nasal swab or bronchoalveolar lavage fluid will be more helpful in diagnosis than sputum gram stains or cultures because of high sensitivity to detect atypical and viral pathogens.
